Único anticonceptivo aprobado por FDA para
el uso en adolescentes.
Original Research Article
Multicenter, open-label trial to assess the safety and tolerability of drospirenone 4.0 mg over 6 cycles in female adolescents, with a 7-cycle extension phase***
Dan Apter, Enrico Colli, Kristina Gemzell-Danielsson, Klaus Peters
VL-Medi Clinical Research Center, Toolonkatu 37, 00260 Helsinki, Finland
Exeltis Spain, Madrid, Spain.
Department of Women’s and Children’s Health, Karolinska Institute, and Karolinska University Hospital,
171 77 Stockholm, Sweeden.
Praxis Dr. Peters, Brener Heerweg 157, 22159 Hamburg, Germany
Mantiene los niveles de estradiol dentro del rango normal, para asegurar la densidad mineral ósea (dmo).
Mantiene los niveles de estradiol
dentro del rango normal.
Bone health in strogen-free contraception
P. Hadji. E. Colli. P.-A. Regidor
International Osteoporosis Fundation and National Osteoporosis Foundation 2019